BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 19241194)

  • 1. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of protamine 1 as a novel cancer-testis antigen in early chronic lymphocytic leukaemia.
    Meklat F; Zhang Y; Shahriar M; Ahmed SU; Li W; Voukkalis N; Wang Z; Zhang J; Mastulov S; Jewell A; Giannakouros T; Lim SH
    Br J Haematol; 2009 Mar; 144(5):660-6. PubMed ID: 19036087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies.
    Wang Z; Zhang Y; Mandal A; Zhang J; Giles FJ; Herr JC; Lim SH
    Clin Cancer Res; 2004 Oct; 10(19):6544-50. PubMed ID: 15475442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEMG-1 expression in early stage chronic lymphocytic leukemia.
    Ahmed SU; Meklat F; Shahriar M; Zhang J; Mastulov S; Giannakouros T; Jewell A; Zhang Y; Lim SH
    Cytotherapy; 2009; 11(2):238-44. PubMed ID: 19241194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of a target for immunotherapy and results of the first Peptide vaccination study in chronic lymphocytic leukemia.
    Tabarkiewicz J; Giannopoulos K
    Transplant Proc; 2010 Oct; 42(8):3293-6. PubMed ID: 20970674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP70 in chronic lymphocytic leukaemia.
    Amin S; Parker A; Mann J
    Int J Biochem Cell Biol; 2008; 40(9):1654-8. PubMed ID: 17625948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is ZAP-70?
    Béné MC
    Cytometry B Clin Cytom; 2006 Jul; 70(4):204-8. PubMed ID: 16906576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
    Le Dieu R; Gribben J
    Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of chronic lymphocytic leukemia: focus on recent biomarkers].
    Véronèse L; Tchirkov A; Gouas L; Périssel B; Goumy C; Vago P
    Ann Biol Clin (Paris); 2008; 66(4):371-7. PubMed ID: 18725337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
    Rosén A; Murray F; Evaldsson C; Rosenquist R
    Semin Cancer Biol; 2010 Dec; 20(6):400-9. PubMed ID: 20863893
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.